文档介绍：中国现代药物应用2021年12月第15卷第24期　Chin J Mod Drug Appl, Dec 2021, Vol. 15, No. 24 ·153·
苯磺酸左旋there
was no statistically significant difference in heart rate, diastolic blood pressure (DBP), and systolic blood pressure
(SBP) between the two groups (P>). After treatment, the heart rate, DBP and SBP of the two groups were better
than those of this group before treatment; the heart rate (±) beats/min, DBP (±) mm Hg
(1 mm Hg= kPa), and SBP (±) mm Hg of the observation group were better than (±
) times/min, (±) mm Hg, (±) mm Hg of the control group; all the differences were
statistically significant (P<). Conclusion Levamlodipine besylate in combination with valsartan for the
treatment of hypertension can not only lower the blood pressure level of patients, but also lower the occurrence of
adverse reactions, and improve the clinical effect. At the same time, it also has high safety and is beneficial to the
recovery of the patient’s health. It is worthy of clinical promotion.
【Key words】　 Levamlodipine besylate; Valsartan; Hypertension
高血压是临床上常见的一种慢性疾病［1］, 严重影为治疗参考。同时 , 科学高效的治疗方法也很重要 , 因
响着患者的生活质量 , 且发病率较高 , 同时会引发诸多此 , 本研究以 106 例高血压患者作为研究对象